Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation
Table 3
Logistic regression model for distinguishing individuals who discontinued treatment due to pulmonary adverse effects employing clinical parameters.